ESTIMATING THE POTENTIAL BUDGET IMPACT OF ZELBORAF (VEMURAFENIB) FOR ADVANCED MELANOMA TREATMENT IN BRAZILIAN PRIVATE HEALTH CARE SYSTEM

被引：0
|
作者：
Tsuchiya, C. T. [1 ]
Buschinelli, C. T. [1 ]
Maximo, M. F. M. [1 ]
Tobaruella, F. S. [1 ]
Borges, L. G. [1 ]
机构：
[1] Roche Brazil, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.641
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A132 / A132
页数：1
相关论文
共 50 条
  • [21] Budget impact of Transdermal Adhesives of Rivastigmine in Brazilian Public Health System
    Bueno, R. L. P.
    Gomes, M.
    Indelli, B.
    VALUE IN HEALTH, 2008, 11 (03) : A138 - A138
  • [22] ECONOMIC IMPACT OF TREATMENT WITH NOVEL ORAL ANTICOAGULANTS VERSUS WARFARIN IN BRAZILIAN PRIVATE HEALTH SYSTEM
    Ferreira, C. N.
    Squiassi, H. B.
    Paloni, E. D.
    Nogueira, F.
    Santana, C. F.
    Paiva, E. C.
    VALUE IN HEALTH, 2016, 19 (03) : A44 - A44
  • [23] BUDGET IMPACT ANALYSIS OF AXITINIB IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA AFTER THE FAILURE OF ONE PRIOR SYSTEMIC THERAPY IN THE BRAZILIAN PRIVATE HEALTH SYSTEM
    Alexandre, R. F.
    Squiassi, H. B.
    Santana, C. F.
    VALUE IN HEALTH, 2017, 20 (05) : A97 - A97
  • [24] BUDGET IMPACT ANALYSIS OF IPILIMUMAB FOR THE TREATMENT OF ADVANCED MELANOMA IN THE VENETO REGION, ITALY
    Adami, S.
    Aiello, A.
    Palozzo, A. C.
    Magri, M. R.
    Visentin, E.
    Chiarion, V
    Michelon, A.
    Alberti, C.
    Maran, P. R.
    Saugo, M.
    Scroccaro, G.
    VALUE IN HEALTH, 2013, 16 (07) : A399 - A399
  • [25] BUDGET IMPACT ANALYSIS OF THE USE OF CONTACT FORCE CATHETER IN ATRIAL FIBRILLATION ABLATIONS IN THE BRAZILIAN HEALTH CARE SYSTEM
    Oliveira, D.
    Junqueira Junior, S. M.
    Oliveira, F. M.
    Luque, A.
    Cabra, H. A.
    VALUE IN HEALTH, 2017, 20 (05) : A265 - A265
  • [26] COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS PERFORMING HIP AND KNEE ARTHROPLASTY IN COMPARISON WITH NO TREATMENT UNDER THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM PERSPECTIVE
    Schiola, A.
    Silva, A. P.
    Santoni, N. B.
    Paladini, L.
    Teich, V
    Pepe, C.
    Rocha, M. M.
    VALUE IN HEALTH, 2011, 14 (07) : A545 - A545
  • [27] THE ECONOMIC COST OF A DEATH EVENT IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM
    Santos, M. C.
    Ferreira, C. N.
    Squiassi, H. B.
    Santana, C. F.
    VALUE IN HEALTH, 2016, 19 (03) : A29 - A29
  • [28] NEWEST TARGET THERAPY AND IMMUNOTHERAPY FOR THE TREATMENT OF ADVANCED MELANOMA: PATTERNS OF ADOPTION BY THE PRIVATE HEALTH CARE SECTOR IN BRAZIL
    Pegoretti Rosa, B.
    Goes, L.
    Moraes, Z.
    Feijo, L.
    Clark, L. G.
    VALUE IN HEALTH, 2017, 20 (09) : A881 - A881
  • [29] BUDGET IMPACT OF GOLIMUMAB IN THE ANTI-TNF TREATMENT OF RHEUMATOID ARTHRITIS, AKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM
    Morais, A. D.
    Pereira, M. L.
    VALUE IN HEALTH, 2012, 15 (07) : A441 - A441
  • [30] AFLIBERCEPT FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A BUDGET IMPACT ANALYSIS UNDER THE PERSPECTIVE OF BRAZILIAN PUBLIC HEALTH CARE SYSTEM
    Oliveira, L. E.
    Caires, A. L.
    Abreu, G. R.
    Nita, M. E.
    VALUE IN HEALTH, 2017, 20 (05) : A156 - A156
12345